A clinicopathologic study of 30 cases of oligoastrocytoma including p53 immunohistochemistry

Pathology

Volumn 29, Issue 2, 1997, Pages 159-164

  Beckmann, Michael J ^a   Prayson, Richard A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Malignant mixed glioma; Mixed glioma; Oligoastrocytoma; p53 antibody

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN P53;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTE; ASTROCYTOMA; CANCER MORTALITY; CANCER RECURRENCE; CHILD; CLINICAL ARTICLE; DISEASE DURATION; FEMALE; FOLLOW UP; FRONTAL LOBE; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; SEIZURE; TEMPORAL LOBE; TUMOR LOCALIZATION;

EID: 0030837167     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313029700169794     Document Type: Article

References (13)

1. Hart MN, Petito CK, Earle KM. Mixed gliomas. Cancer 1974; 33: 134-40.
2. Kleihues P, Burger PC, Scheithauer BW. Histiological Typing of Tumours of the Central Nervous System, ed. 2. Berlin: Springer-Verlag, 1993; 19-20.
3. Burger PC, Scheithauer BW. Tumors of the Central Nervous System. In: Atlas of Tumor Pathology. Washington DC: Armed Forces Institute of Pathology, 1994; 25-161.
4. Mørk SJ, Halvorsen TB, Lindegaard K-F, Eide GE. Oligodendroglioma. Histologic evaluation and prognosis. J Neuropathol Exp Neurol 1986; 45(1): 65-78.
5. Burger PC, Rawlings CE, Cox EB, McLendon RE, Schold Jr SC, Bullard DE. Clinicopathologic correlations in the oligodendroglioma. Cancer 1987; 59: 1345-52.
6. Karamitopoulou E, Perentes E, Diamantis I. p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies. Acta Neuropathol 1993; 85: 611-6.
7. Haapasalo H, Isola J, Sallinen P, Kalimo H, Helin H, Rantala I. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation. Am J Pathol 1993; 142(5): 1347-51.
8. von Deimling A, Eibl RH, Ohgaki H, et al. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res 1992; 52: 2987-90.
9. Bruner JM, Saya H, Moser RP. Immunocytochemical detection of p53 in human gliomas. Modern Pathology 1991; 4(5): 671-4.
10. Chozick BS, Weicker ME, Pezzullo JC, et al. Pattern of mutant p53 expression in human astrocytomas suggests the existence of alternate pathways of tumorigenesis. Cancer 1993; 73(2): 406-15.
11. Sarkar FH, Kupsky WJ, Li YW, Sreepathi P. Analysis of p53 gene mutations in human gliomas by polymerase chain reaction-based single-strand conformation polymorphism and DNA sequencing. Diagn Mol Pathol 1994; 3: 2-8.
12. Louis DN. The p53 gene and protein in human brain tumors. J Neuropathol and Exp Neurol 1994; 53(1): 11-21.
13. Ali IU, Schweitzer JB, Ikejiri B, Saxena A, Robertson JT, Oldfield EH. Heterogeneity of subcellular localization of p53 protein in human gliomas. Cancer Res 1994; 54: 1-5.